Search

Learn how a second opinion at a highly specialized cancer center such as MSK can lead to treatment that costs less and improves quality of life and survival.

… Tuesday, January 20, 2026 Many people who get a second opinion from highly specialized cancer experts may benefit from treatment that costs less, is less invasive, and improves quality of life and survival, according to new research conducted at Memorial Sloan Kettering Cancer Center (MSK). The study

For RuthAnn (“Ruthy”) Gordon, Director of Clinical Trials Nursing, some of the best days are when the FDA approves a drug from a clinical trial that she worked on. It’s happened to her four times.

… Monday, May 9, 2022 Clinical trials are research studies that test new drugs and therapies. MSK runs one of the largest clinical trials programs for cancer in the country — at any time, hundreds of clinical trials are underway at MSK locations in New York City and across the regional care network. Patients

… Friday, September 13, 2024 Alan Ho, MD, PhD , has been named the Chief of the Head and Neck Oncology Service within the Division of Solid Tumor Oncology in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). Dr. Ho currently serves as a Head and Neck Medical Oncologist and a Cellular

Learn how child psychologist Stephen Sands supports pediatric patients at Memorial Sloan Kettering.

… Tuesday, September 12, 2017 Summary Child psychologist Stephen Sands explains his role in supporting MSK’s pediatric patients through their cancer treatment and beyond. Children with cancer face the disease during a time of intense growth and development. At Memorial Sloan Kettering, pediatric neuropsychologist

Researchers discover that a curious type of cell death plays a role in normal development.

… Thursday, March 28, 2019 Summary Researchers have found that a process called entosis plays a role in the development of the C. elegans worm. In biology, how cells die is as important as how they live. Cell death provides a counterbalance to cell division, maintaining the proper number of cells throughout

Memorial Sloan Kettering Cancer Center (MSK) has announced that Kreg Koford has been named MSK's Senior Vice President of Supply Chain and Sustaining Care Services. Mr. Koford assumes his new role at MSK on July 9, 2018.

… Tuesday, July 10, 2018 Memorial Sloan Kettering Cancer Center (MSK) has announced that Kreg Koford has been named MSK’s Senior Vice President of Supply Chain and Sustaining Care Services. Mr. Koford assumes his new role at MSK on July 9, 2018. With his significant experience in strategic sourcing, category

A celebration over Zoom allowed MSK bone marrow transplant survivors to reminisce with medical staff and each other.

… Wednesday, October 7, 2020 “We all live in incredible times.” Those were the words of Sergio Giralt , a bone marrow transplant (BMT) expert at Memorial Sloan Kettering. On October 5, he opened MSK’s 25th annual celebration for transplant survivors by explaining that the rise of COVID-19 had prompted

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its next President and Chief Executive Officer.

… Monday, June 27, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its

Deb Schrag, MD, MPH, has been named the new Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

… Monday, October 4, 2021 Deb Schrag, MD, MPH, has been named the new Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished healthcare leader, clinician, researcher, and expert in public health and population science, Dr. Schrag has a deep familiarity with

Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute.

… Monday, March 1, 2021 Summary Kathryn Anderson, the founding Chair of the Developmental Biology Program in the Sloan Kettering Institute, died in November 2020. Here, some of her colleagues remember her generous spirit and contributions to women in science. Kathryn Anderson was once asked to explain